The EFTUD2 gene helps cells edit RNA, a step they need before making many proteins. The protein made by this gene helps your cells process genetic instructions in a steady way during early development. A harmful variant can cause a condition called mandibulofacial dysostosis, Guion-Almeida type, which may affect the shape of the face and ears, hearing, feeding, growth, and learning. EFTUD2 is mainly known in medical genetics rather than popular culture.
What is a gene?
Genes are stretches of DNA that hold instructions cells use to make molecules or manage activities in the body. Some genes provide the code for proteins, which do much of the cell’s work. Others are involved mainly in regulating when certain processes happen, where they happen, and how active they are. Taken together, genes affect how the body develops and functions, and they can also influence your response to food, stress, or medications. More detail is available in the LearnHub.
Overview
EFTUD2Gene function
What if the gene works
The EFTUD2 gene helps cells edit genetic messages before they are used to make proteins. This supports normal cell function, growth, and development.
Risk
What if the gene does not work
Changes in the EFTUD2 gene are linked to a condition that can affect face and jaw development, hearing, feeding, growth, and learning. Milder to more severe variants can influence which features appear and how strongly a person is affected.
Treatment
What does that mean for your treatment
A pathogenic or loss-of-function variant in the EFTUD2 gene does not currently point to a gene-specific medicine or management plan. Care is individualized and may include feeding, hearing, speech, dental, or craniofacial support based on the person's needs. The EFTUD2 gene is also being studied as a biomarker and possible treatment target in some cancers.
Conditions associated with EFTUD2
Gene function
What if the gene works
In your cells, the EFTUD2 gene helps process RNA messages before they are used to make proteins. This keeps everyday cell activity organized and efficient. Understanding how the EFTUD2 gene supports RNA splicing helps show how your body turns genetic instructions into workable protein plans.
The EFTUD2 gene helps remove extra sections from RNA and join the useful parts together. This editing step prepares a clear set of instructions for making proteins.
Inside your cells, the EFTUD2 gene helps run the spliceosome, a cell machine that edits RNA. Its protein uses energy to help this machine shift shape at the right time.
By helping RNA messages mature correctly, the EFTUD2 gene supports when and how proteins are made. This helps many basic cell tasks stay steady across different tissues.
What is a variant?
A genetic variant is a small difference in the DNA sequence within a gene. These differences are common and help make up normal human diversity, including variations in appearance, metabolism, and how the body responds to environmental influences. Many have no noticeable effect and simply represent natural genetic variation. In some situations, though, a variant can more strongly affect how a gene functions and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Many variants in the EFTUD2 gene weaken or shorten the protein, which can disrupt RNA splicing (the cell’s editing of gene messages). This is how variants in the EFTUD2 gene change protein function: some missense variants alter key working sites, while more severe variants can stop the protein from being made at all. A larger loss of function may be linked to earlier or more marked features of EFTUD2 related craniofacial and developmental conditions, although severity varies.
How variants are linked to conditions
Pathogenic EFTUD2 gene variants cause mandibulofacial dysostosis, Guion-Almeida type, a rare condition that affects development of the face and head. Many people with this diagnosis have ear differences, hearing loss, a cleft palate, or feeding difficulties early in life. Some also have developmental delay or learning difficulties, although the pattern and severity can vary.
A variant is not necessarily a diagnosis
Genetic variants are common across the general population and are a normal feature of human biology. Most do not directly affect health and instead reflect natural differences among people. For many genes, having a variant associated with a condition points to a possible link rather than a certain diagnosis, particularly when more than one gene and environmental influences are part of the picture. In some situations, though, one well characterized variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For EFTUD2, risk is mainly tied to whether a disease-causing gene change is present, often from birth, rather than to lifestyle or everyday exposures. There is not enough evidence to say that diet, exercise, or other habits lower the chance of developing the related condition. In families with an EFTUD2 change, the main risk difference is whether the variant was inherited or happened new in the child.
Inheritance of EFTUD2 variants
EFTUD2 gene variants linked to EFTUD2-related conditions are usually inherited in an autosomal dominant pattern. This means a person needs one altered copy of the EFTUD2 gene to have the condition, and an affected parent has a 50% chance of passing it to each child. In many families, the variant happens for the first time in the child as a new (de novo) change, rather than being inherited from either parent. When that happens, brothers and sisters usually have a low chance of having the same variant, while the affected person can still pass it on to future children.
What does my EFTUD2 result mean for my family?
Changes in the EFTUD2 gene are usually linked to a condition that follows a dominant inheritance pattern, so close relatives such as a parent, child, brother, or sister may also carry the same gene change. If a parent has the same change, each child has a 50% chance of inheriting it. Some EFTUD2 changes happen for the first time in one person, so a parent may not have the variant.
Genetic information
Genetic testing
How you find out about variants
EFTUD2 genetic testing looks for variants in the EFTUD2 gene using a blood sample, saliva, or a cheek swab. Most labs read the gene’s DNA sequence and may also check for missing or extra pieces, which can help confirm whether an EFTUD2 variant is present. Results are interpreted alongside medical findings and family history.
When should I consider getting a genetic test?
Genetic testing for the EFTUD2 gene may be considered when a child has a pattern of findings present from birth, such as small head size, differences in the jaw or ears, hearing loss, feeding problems, or developmental delay. It can also help when a parent or close relative has the same condition or a known EFTUD2 variant.
A genetic result is only one part of your health story
A genetic finding can provide useful insight, but how much it explains depends on the condition and the type of variant present. Factors such as lifestyle, environment, age, and medical history also shape how the body functions over time. For some conditions, especially those influenced by many genes, genetic information offers context rather than certainty and is best understood together with other parts of care. In other situations, a genetic result can give a clear answer. In areas such as medication response, genetic results can also help place personal experiences in context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how your body handles certain medicines, so the same treatment may work differently from one person to another. Some people break down a drug more slowly or more quickly, while others may be more or less sensitive to its effects. This can influence how well a medicine works and the chance of side effects, which is why medication response often varies between individuals.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences affect the way people respond to medications. It studies gene and drug patterns to understand why the same treatment can work differently from one person to another. For many medicines, genes influence how strongly a medication works or how the body handles it. This information can support more informed and more individualized treatment decisions. More detail on this topic is available in the LearnHub.
Drugs influenced by the EFTUD2 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in predicting how medicines will work or what side effects they may cause, so general questions about treatment, side effects, or new symptoms are best discussed with your doctor.
History
Mandibulofacial dysostosis now linked to the EFTUD2 gene was first recognized through the shared facial and developmental features seen in a small number of children, including reports by Guion-Almeida and colleagues in the early 2000s. Initially understood only through visible traits, later recognized as tied to a specific gene, the condition took a clearer shape when researchers identified EFTUD2 variants through exome sequencing in 2012. From these first observations, research expanded steadily. Additional reports from different countries confirmed the link and showed that people can be affected in somewhat different ways. This work helped establish EFTUD2 as part of a broader group of genes involved in how cells process genetic messages.